Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2019

Apr 30, 2019

32206_dirs_2019-04-30_8f266ede-19e6-49fa-98db-82c8b3acbc14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2019-04-26

Reporting Person: Landy Mark (EVP & Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-04-26 Common Stock A 104271 $2.41 Acquired 208336 Direct
2019-04-26 Common Stock A 175000 $2.41 Acquired 383336 Direct

Footnotes

F1: Represents annual grant of restricted stock which vests one-third on each anniversary.

F2: Represents special retention grant of restricted stock which vests one-third on each anniversary.